Shanaka K A S N, Wilathgamuwa S, Gunawardene Y I N S, Dassanayake R S
1Department of Chemistry, Faculty of Science, University of Colombo, Colombo, Sri Lanka.
2Durdans Hospital (Pvt) Ltd, No.03 Alfred Place, Colombo 3, Sri Lanka.
Virusdisease. 2018 Mar;29(1):27-31. doi: 10.1007/s13337-018-0419-7. Epub 2018 Feb 15.
Human papilloma virus (HPV) causes cervical cancer in women and approximately 700 deaths have been reported annually in Sri Lanka due to this cancer. Despite, attempts have not been made to investigate the prevalence of HPV amongst Sri Lankan women with normal cytology. In this study, a polymerase chain reaction based assay was set up to detect HPV in both normal and abnormal cytology and the positive samples were then tested for the genotypes, HPV 16 and HPV 18 as they have been identified as the high-risk types associating with cervical cancer. Eighty-four (number = 84) clinical samples (age range 27-69) analyzed in this study indicated that the prevalence of HPV, regardless of cytological abnormalities was 15.5%, (n = 13, 95% class interval ± 7.7) while it was 100% (n = 3) for those with abnormal cytology. Association of HPV 16 and HPV 18 among the abnormal cytology was 0 and 50% (n = 1), respectively and further, the prevalence of HPV 16 and HPV 18 in women was found to be 3.6% (n = 3, 95% CI ± 4.0) and 2.4% (n = 2, 95% CI ± 3.3), respectively. Moreover, age wise prevalence analysis revealed women of the age of 35-years or more to have higher HPV prevalence. The prevalence of HPV among normal cytology is 12.3% (n = 10, 95% CI ± 7.2) which is similar to the rates in other regions of Asia (China 15.4%; India 10.43%). Finally, higher prevalence of HPV in women of the age of 35-years or more in Sri Lanka, especially with malignant types call for such age group to be screened for proper clinical intervention to be made in reducing the incident of cervical cancers. This is the first report of prevalence of HPV among women with normal cytology in Sri Lanka.
人乳头瘤病毒(HPV)可导致女性患宫颈癌,在斯里兰卡,每年约有700人死于这种癌症。尽管如此,尚未有人尝试调查细胞学检查正常的斯里兰卡女性中HPV的流行情况。在本研究中,建立了一种基于聚合酶链反应的检测方法,用于检测正常和异常细胞学样本中的HPV,然后对阳性样本进行HPV 16和HPV 18基因型检测,因为它们已被确定为与宫颈癌相关的高危类型。本研究分析的84份临床样本(年龄范围27 - 69岁)表明,无论细胞学是否异常,HPV的流行率为15.5%(n = 13,95%置信区间±7.7),而细胞学异常者的HPV流行率为100%(n = 3)。在细胞学异常样本中,HPV 16和HPV 18的关联率分别为0和50%(n = 1),此外,女性中HPV 16和HPV 18的流行率分别为3.6%(n = 3,95%置信区间±4.0)和2.4%(n = 2,95%置信区间±3.3)。此外,按年龄进行的流行率分析显示,35岁及以上女性的HPV流行率较高。细胞学正常者中HPV的流行率为12.3%(n = 10,95%置信区间±7.2),这与亚洲其他地区的比率相似(中国为15.4%;印度为10.43%)。最后,斯里兰卡35岁及以上女性中HPV的高流行率,尤其是恶性类型,要求对该年龄组进行筛查,以便采取适当的临床干预措施来降低宫颈癌的发病率。这是斯里兰卡细胞学检查正常女性中HPV流行率的首次报告。